Catalyst Pharmaceuticals Inc (CPRX)

Fixed asset turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	US$ in thousands	491,734	398,204	214,203	140,833	119,073
Property, plant and equipment	US$ in thousands	—	—	847	3,976	130
Fixed asset turnover		—	—	252.90	35.42	915.95

December 31, 2024 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $491,734K ÷ $—K
= —

Fixed asset turnover is a financial ratio that measures how efficiently a company generates revenue from its investments in fixed assets. Looking at the data provided for Catalyst Pharmaceuticals Inc, we see a significant decline in the fixed asset turnover ratio from 915.95 in December 2020 to 35.42 in December 2021. This sharp decrease suggests a potential decrease in the company's ability to generate revenue from its fixed assets.

However, there seems to be a recovery in the fixed asset turnover ratio in December 2022, with a ratio of 252.90. This improvement indicates that the company may have become more efficient in utilizing its fixed assets to generate revenue. It is important to note that there is missing data for December 2023 and December 2024, which limits our ability to assess the trend over the entire period.

In conclusion, the fluctuation in Catalyst Pharmaceuticals Inc's fixed asset turnover ratio raises some concerns about the company's efficiency in utilizing its fixed assets to generate revenue. Further analysis and additional data would be needed to fully understand the underlying reasons behind these fluctuations.